Trusted Resources: People & Places
Online groups, photo galleries and blogs
Walla Al-Hertani, MD, MS, FRCPC, FCCMG, FACMG
Healthcare Professional Director
Lysosomal Storage Disease Program (BoLD)
Boston Children's Hospital
300 Longwood Avenue, Fegan, 4th Floor
Boston, Massachusetts, United States
Dr. Walla Al-Hertani is a Medical Biochemical Geneticist and a Clinical Geneticist practicing at Boston Children’s Hospital and an Assistant Professor of Pediatrics at Harvard Medical School. She received her Doctor of Medicine degree from Dalhousie University in Halifax, Nova Scotia, followed by the completion of her Clinical Genetics residency in Ottawa and a Biochemical Genetics fellowship at the Hospital for Sick Children and the University of Toronto. Dr. Al-Hertani is currently the Director of the Lysosomal Diseases Program, Glycogen Storage Diseases Program and the Assistant Director of the Metabolism Program at Boston Children’s Hospital. She is actively involved with a number of clinical trials investigating innovative therapies for rare diseases.
Dr. Al-Hertani also specializes in inborn errors off metabolism, lysosomal storage diseases, Glycogen Storage Diseases, Gaucher disease, Pompe Disease, Niemann Pick Disease Type C, MPSI, MPSII, MPSIII, MPSIVA, MPSVI, GSD1a, GSD1b, GSD3, GSD6, GSD9, Methylmalonic acidemia, Propionic acidemia, X-Linked Adrenoleukodystrophy, Peroxisomal disorders, Mitochondrial disorders and Genetic disorders.
Related Content
-
Carpal Tunnel Syndrome and Finger Deformities in Children With Mucopolysaccharidoses and Mucolipidoses: A Retrospect...This single-centre retrospective study r...
-
Bob StevensBob Stevens is Group Chief Executive Off...
-
MPSBase: Comprehensive Repository of Differentially Expressed Genes for MucopolysaccharidosesMucopolysaccharidoses (MPS) are lysosoma...
-
Oxidative Stress in Mucopolysaccharidoses: Pharmacological ImplicationsAlthough mucopolysaccharidoses (MPS) are...
-
Mucopolysaccharidoses Fact SheetThe mucopolysaccharidoses are a group of...
-
Disease Manifestations in Mucopolysaccharidoses and Their Impact on Anaesthesia-Related Complications-A Retrospectiv...Patients with mucopolysaccharidoses (MPS...
-
Mucopolysaccharidosis Type 1 (MPS 1)What is Mucopolysaccharidosis Type 1?Muc...